Patent Assignment
Reel/Frame 037503/0720
Assignment of Assignor's Interest
Recorded: 2016-01-15
Pages: 8
Assignors
FOSTER, AARON EDWARD
Executed: 2015-11-18
SPENCER, DAVID
Executed: 2015-06-04
COLLINSON-PAUTZ, MATTHEW ROBERT
Executed: 2015-11-12
SLAWIN, KEVIN
Executed: 2015-11-20
Assignee
BELLICUM PHARMACEUTICALS, INC.
2130 WEST HOLCOMBE BLVD., SUITE 850, HOUSTON, TEXAS, 77030
Covered Properties
(2)
Methods for Activating T Cells Using an Inducible Chimeric Polypeptide
PCT:
PCT/US2015/015829 ↗
MODIFIED T CELL COMPRISING A POLYNUCLEOTIDE ENCODING AN INDUCIBLE STIMULATING MOLECULE COMPRISING MyD88, CD40 AND FKBP12
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Apr 1, 2020
From: BELLICUM PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 052284/0113 →
Release of Security Interest
Nov 3, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 054295/0946 →
Assignment of Assignor's Interest
Feb 21, 2024
From: BELLICUM PHARMACEUTICALS, INC.
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 066643/0549 →